On June 22, Shimadzu Corporation commenced trial sales of its Gut Bacteria Co-Culture Device (hereinafter “the Device”). The Device creates the mimicked environment of the human gut that allows the co-culture*1 of intestinal epithelial cells and gut bacteria. The technologies used in the Device were developed through the joint research with Professor Takane Katayama of the […]

MINNEAPOLIS and TOLOCHENAZ, Switzerland — Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Lunaphore, Inc. Bio-Techne anticipates the acquisition to close in the first quarter of its fiscal 2024. Founded in 2014 and headquartered in […]

Platform selected to accelerate precision fermentation workflows, to support more sustainable and cost-effective manufacturing for active ingredients in vitamins and bioactives Early results demonstrate significant savings in time and resources applicable across a wide range of synthetic biology applications Cambridge, UK, and Copenhagen, Denmark: Sphere Fluidics, a company developing single cell analysis systems underpinned by its […]

·        Investment in new global headquarters forms part of ongoing growth plans ·        Bespoke lab and office space designed to foster innovation and collaboration with colleagues and customers Greater London, UK: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced it will relocate its Greater London global […]

LEIDEN, the Netherlands — MIMETAS, a global leader in human disease modeling announces that it has expanded its ongoing partnership with Astellas, a global pharmaceutical company, to include automation and application support. “We are truly honored by the trust of the Astellas team in our capabilities,” says Paul Vulto, CEO of MIMETAS. “Astellas is a true innovation leader that […]

Curia signs license agreement with MilliporeSigma to support production of proteins and antibodies Albany, NY — Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt, Germany, that enables Curia and its clients to use the CHOZN® […]

Has served in interim role since January 2023 HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of Jennifer Cote as the Company’s Chief Financial Officer and Treasurer, effective June 19, 2023. Cote joined the Company as Vice President of Global Finance in May 2022 and has served as Interim […]

Cologne, Germany — “We care for your samples, you care for science” – Singleron holds true to their slogan as reliable partner to scientists and clinicians. Developing single cell multi-omics products that can be used in research and clinical settings, the launch of two new instruments extends their current portfolio that delivers one-stop-shop solutions for […]

New collaboration will provide both companies’ customers access to enhanced digital technologies for faster, more flexible, cost-effective, and more predictable scaling When used in collaboration, the two companies’ technologies are expected to reduce process waste and costs for customers’ target molecule milestones Availability of Cytiva cell culture media and data analytics software to Culture Biosciences […]

Hayward, CA – Biolog, Inc., a leading provider of microbial polyphasic analysis, today announced the launch of the Odin™ system, an all-in-one cellular phenotyping and microbial identification platform. Odin is compatible with all Biolog assays and is available now. Until today, Biolog’s OmniLog® platform was the gold standard for researchers who want actionable insights on […]